Genomics bioinformatics platform developer PierianDx has raised capital from investors including Inova Health Systems and RTI International to advance its business strategy.
PierianDx, a US-based genomic bioinformatics platform developer founded on Washington University in St Louis research, has closed a $27m series B round backed by healthcare provider Inova Health Systems.
ATW Partners and SJF Ventures co-led the round, which also included research services provider RTI International, national reference laboratory Arup Laboratories and Health Catalyst Capital.
Founded in 2014, PierianDx has created a medical diagnostics platform with informatics software tools that facilitate molecular-level genomic sequencing of the patient’s DNA to determine the…
